ArticlePapillomavirus research (Amsterdam, Netherlands)2016
HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
Article in Papillomavirus research (Amsterdam, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.
- Human papillomavirus vaccination at age 9 or 10 years to increase coverage - a narrative review of the literature, United States 2014-2024.Human vaccines & immunotherapeutics · 2025Pooled it
- Advancements and Future Perspectives of Human Papillomavirus (HPV) Vaccination in Latin America: Insights from Recent Decades.Healthcare (Basel, Switzerland) · 2025Review
- HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.Human vaccines & immunotherapeutics · 2023Article
- Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems.Nature reviews. Drug discovery · 2023Review
- Awareness about Human Papillomavirus Vaccine and Its Uptake among Women from North India: Evidence from a Cross-Sectional Study.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Social determinants of human papillomavirus vaccine series completion among U.S. adolescents: A mixed-methods study.SSM - population health · 2022Article
- Article
- U.S. Vietnamese Mothers' HPV Vaccine Decision-Making for Their Adolescents: A Qualitative Study.Journal of health care for the poor and underserved · 2022Article
- Maternal HPV Infection: Effects on Pregnancy Outcome.Viruses · 2021Review
- Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents.American journal of preventive medicine · 2021Article
- Factors associated with HPV vaccination initiation among United States college students.Human vaccines & immunotherapeutics · 2021Article
- Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.American journal of preventive medicine · 2021Article
- Associations between insurance-related affordable care act policy changes with HPV vaccine completion.BMC public health · 2021Article
- Barriers to Human Papillomavirus Vaccine Series Completion among Insured Individuals in an Integrated Healthcare Setting.Infectious diseases · 2021Article
- Human Papillomavirus Vaccination Schedule: Adherence Among Commercially Insured Adolescents and Young Adults in the United States, 2011-2017.American journal of public health · 2020Article
- Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria.Journal of family medicine and primary care · 2019Article
- Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.The Milbank quarterly · 2018Article
- Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients.American journal of public health · 2018Article
- Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.Vaccine · 2018Article
- Is HPV vaccination in pregnancy safe?Human vaccines & immunotherapeutics · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
backgroundAlthough HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US.
methodsWe conducted a retrospective cohort study using the 2008-2011 MarketScan data to examine HPV vaccine completion and dose adherence among commercially insured females aged 9-26 years. We performed multivariable logistic regression models to examine factors related to HPV vaccine completion and HPV vaccine dose adherence.
resultsAmong 378,484 females aged 9-26 years who initiated HPV vaccination, only 29.4% completed HPV vaccination. Compared with females receiving vaccines from primary care providers, those receiving vaccines from OB/GYN providers were more likely to complete the vaccine series. Age at HPV vaccine initiation, health insurance plan, seasonal pattern, and flu vaccination were also significantly associated with vaccine completion. Among 111,286 females who completed HPV vaccination, 62.4% received all doses within 30 days of the recommended schedules. Similar factors relating to HPV vaccine completion were consistently associated with HPV vaccine dose adherence. However, younger age (<22 years) and receipt of flu vaccine were negatively related to HPV vaccine dose adherence.
conclusionsIntervention programs to improve HPV vaccine reminding system and reduce logistic barriers for both physicians and patients are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.